Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets

v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 20,312 $ 19,206
Marketable securities 76,438 0
Accounts receivable, net (including allowance of $364 and $148 as of September 30, 2025 and December 31, 2024, respectively) 5,808 11,926
Contract assets 3,950 785
Other current assets 6,524 3,278
Assets classified as held for sale 0 56,963
Total current assets 113,032 92,158
Property and equipment, net 75,261 63,338
Operating lease right-of-use assets 10,206 11,074
Goodwill 15,222 14,735
Other intangible assets 9,332 10,161
Other long-term assets 1,204 2,109
Total assets 224,257 193,575
Current liabilities    
Accounts payable 11,368 11,592
Long-term debt, current portion 0 93,936
Contract liabilities, current portion 28,006 22,037
Other accrued expenses 20,020 16,361
Liabilities associated with assets classified as held for sale 0 7,667
Total current liabilities 59,394 151,593
Contract liabilities, non-current 21,640 23,489
Warrant liability 201 13,641
Operating lease liabilities, net of current portion 8,354 9,598
Other long-term liabilities 1,539 6,941
Total liabilities 91,128 205,262
Commitments and contingencies (Note 10)
Stockholders' equity    
Common stock, $0.0001 par value, 1,000,000,000 Class A and 15,000,000 Class B shares authorized, 32,714,550 Class A and 1,507,325 Class B shares issued and outstanding at September 30, 2025; 25,711,165 Class A and 1,507,325 Class B shares issued and outstanding at December 31, 2024 3 3
Additional paid-in capital 601,588 536,725
Accumulated other comprehensive loss (6,216) (9,770)
Accumulated deficit (462,246) (538,645)
Total stockholders' equity (deficit) 133,129 (11,687)
Total liabilities and stockholders' equity $ 224,257 $ 193,575